Medical Xpress
FDA approves another over-the-counter naloxone nasal spray
The FDA has approved Rextovy, a new over-the-counter naloxone nasal spray from Amphastar Pharmaceuticals, expanding access to emergency opioid overdose treatment without a prescription. The approval adds a second nonprescription intranasal option to the market, increasing competition that could drive down costs. With overdose deaths remaining a persistent public health crisis, broader availability of naloxone remains a critical intervention tool.
Read article →Medical Xpress
Mass spectrometry platform could shrink cancer drug discovery cycle to four hours
Purdue researchers have built a mass spectrometry platform that compresses a critical bottleneck in cancer drug discovery — compound screening — down to just four hours. The technology targets one of the field's most stubborn obstacles: the slow, resource-intensive process of identifying viable therapeutic candidates. If it scales, this could fundamentally reshape how quickly new cancer treatments move from lab bench to clinical pipeline.
Read article →NPR Health
A top pulmonologist reviews advancements in the 'War on Cancer' over the past 50 years
Five decades into the so-called War on Cancer, the United States has made measurable but uneven progress against the disease. Dr. Robert A. Winn, a leading pulmonologist, spoke with NPR's Scott Simon about the breakthroughs in treatment, early detection, and survival rates that have reshaped oncology. The conversation underscores both how far medicine has come and how much ground remains to be covered.
Read article →Medical Xpress
Prehab can boost seniors' recuperation from spinal fusion surgery, trial finds
Older adults who undergo targeted exercise and conditioning programs before spinal fusion surgery recover faster and experience fewer post-operative complications, according to new trial findings. The research adds growing weight to the concept of prehabilitation — preparing the body for surgery rather than simply reacting to its aftermath. For an aging population facing rising rates of spinal procedures, the implications for surgical outcomes and healthcare costs could be significant.
Read article →Medical Xpress
First new US sunscreen ingredient since 1999 approved by FDA. A skin scientist explains how bemotrizinol works
The FDA has approved bemotrizinol, the first new sunscreen active ingredient cleared for use in the United States in over 25 years. The molecule works by absorbing a broad spectrum of UV radiation — both UVA and UVB — and converting it to heat rather than allowing it to damage skin cells. The approval ends a lengthy regulatory lag that left American consumers with fewer protective options than those available in Europe and Asia for decades.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →